“…VDAC2 as a channel protein at the outer mitochondrial membrane 28 , in order to enhance the therapeutical effect of inhibition of VDAC2 malonylation, a new nano material, TPP-AAV(AAV(K46Q)@TPP-PEG@ODs), which could target mitochondria to inhibit VDAC2 malonylation was synthetized ( Figure 6 A ). TPP-COOH 1H NMR features are as δ 12.01 (s, 1H-COOH), 7.91-7.75 (m, 15H, Ar-H), 3.62-3.53 (m, 2H, -CH2-), 2.17-2.14 (m, 2H, -CH2-), 1.5 (s, 6H, -CH2-).…”